Treatment
Tildrakizumab clinical trials
We’re tracking 5 recruiting studies that include Tildrakizumab, each written for real people, not researchers, below.
Recruiting studies
- NCT03992729Recruiting
Study tracking pregnancy outcomes after tildrakizumab use
This study follows pregnant people who took tildrakizumab to understand pregnancy outcomes and safety. It also compares them with pregnant people with the same underlying disease who did not take tildrakizumab during this pregnancy.
San Diego, CaliforniaAges Any age - NCT05390515RecruitingPhase 4
Study immune response in adults with psoriasis on tildrakizumab
This trial studies how the immune system responds in adults with moderate-to-severe psoriasis when receiving tildrakizumab. The goal is to better understand treatment effects and immune changes, which may help improve care for people with psoriasis.
San Francisco, CaliforniaAges 18–75 - NCT06029257Recruiting
A study of tildrakizumab for genital psoriasis
This trial tests whether tildrakizumab, a biologic medicine, can help people with psoriasis that affects their genital area. It aims to see if the drug reduces symptoms like redness and scaling in those sensitive regions.
Graz, StyriaAges 18–99 - NCT06030076Recruiting
Switching to tildrakizumab for moderate to severe psoriasis
This trial is for adults with moderate to severe plaque psoriasis who are currently on a biologic treatment (like Humira, Stelara, or Cosentyx) and are switching to tildrakizumab. It looks at how your quality of life and symptoms change after the switch.
Graz, StyriaAges 18 years+ - NCT07370766Recruiting
Tildrakizumab for moderate-to-severe psoriasis in Canada
This study looks at how well tildrakizumab works for people with moderate-to-severe plaque psoriasis who are starting this treatment through a support program in Canada. Researchers want to see how it affects your symptoms and daily life.
Burlington, OntarioAges 18 years+
What Tildrakizumab is being studied for
Conditions with recruiting Tildrakizumab studies.
Common questions
- Are there clinical trials studying Tildrakizumab?
- Yes. Clin2 currently lists 5 recruiting studies that include Tildrakizumab, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Tildrakizumab trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Tildrakizumab an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Tildrakizumab or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.